An international research team has conducted a clinical trial sponsored by Roche and Ionis Pharmaceuticals, that has demonstrated an experimental drug that can safely lower levels of the mutant protein associated with Huntington disease. The results were recently...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok